Stocks Rotation Con...
Health Care: Health Services
Oculus Innovative Sciences Inc. (OCLS: NASDAQ)
$0.89 -0.07 | -6.93%
02/09/12 - 04:00 PM ET
510.03K / 87.90K
Vol / Avg. Vol:0.95 / 0.96
Open / Prev. Close:0.83 - 1.00
Today's Range:0.95 - 2.33
52 Wk Range:-8.57%
Performance YTD:TheStreet Rating:
Portfolios with OCLS
- Portfolio NameUser Type
- ContributorBarron's Insider Purchases ...
- Userkmwoods Portfolio 1
- UserSTEVIE STOCK Portfolio 1
- Userezplan1
- UserJunk3t Portfolio 1
- UserMacktacular
- Userokerman Portfolio 1
- Usercgp7287 Portfolio 1
- UserMW Lamb Portfolio 1
- UserStefan's Selects
Latest OCLS Headlines from TheStreet
- Oculus Partner Misleads on Wound Cleaner 07.07.11 | 08:07 am
- Oculus Innovative Sciences Posts CEO's Presentation From The Roth Capital Partners 23rd Annual Growth Stock Conference 03.24.11 | 08:03 am
- Rodman Rambles: The Biotech Dreck 09.15.10 | 08:09 am
- Perma-Fix, Oculus: Early Volume Plays 03.10.10 | 10:03 am
- Oculus, Bianco and Cel-Sci Oh My!: BioBuzz 11.06.09 | 10:11 am
- Oculus Insider to Sell Microcyn: BioBuzz 09.29.09 | 01:09 pm
- Biotech Stock Mailbag: Geron, Oculus, BioSante 08.19.09 | 11:08 am
- Vanda, Oculus, Sequenom: Biotech Notebook 08.11.09 | 07:08 am
- Inside Oculus and BioCryst's Future
08.02.09 | 06:08 am - Inside Oculus and BioCryst's Future 07.29.09 | 08:07 am
Press Releases for OCLS
- Vista Partners Updates Coverage On Oculus Innovative Sciences, Inc.; Maintains $3.81 Target Price - PR Newswire 06.30.11 | 09:06 am
- Amneal And Oculus Innovative Sciences Announce Broad Multi-Market, Multi-Product Collaboration For Microcyn®-Based Drugs And Devices - Business Wire 02.15.11 | 08:02 am
- Oculus Innovative Sciences Receives New FDA 510(k) Clearance For Microcyn-Based Dermatology HydroGel For Management Of Atopic Dermatitis, Radiation Dermatitis And Other Skin Dermatoses - Business Wire 02.08.11 | 08:02 am
- Oculus Innovative Sciences Reports Record Third Quarter Revenue For Fiscal Year 2011, Exceeding Guidance - Business Wire 02.03.11 | 04:02 pm
- Oculus Innovative Sciences Announces Fiscal Third Quarter 2011 Financial Results And Conference Call - Business Wire 01.20.11 | 08:01 am
- Oculus Innovative Sciences To Present At OneMed Forum 2011 During JP Morgan Week In San Francisco - Business Wire 01.06.11 | 08:01 am
- XuSorb(tm) Foam Wound Care Dressing Is Compatible With Microcyn(r) Technology Wound Care Products. (Photo: Business Wire) - Business Wire 11.10.10 | 08:11 am
- Oculus Innovative Sciences Enters Into Commercial Partnership With Onset Therapeutics - Business Wire 11.08.10 | 08:11 am
- Oculus Innovative Sciences Reports Record Revenue In Second Quarter Fiscal-Year 2011, Exceeding Guidance - Business Wire 11.04.10 | 04:11 pm
- Oculus Innovative Sciences Announces Fiscal Second Quarter 2011 Financial Results And Conference Call - Business Wire 10.26.10 | 08:10 am
Partner Headlines for OCLS
- LifeTech Capital Maintains Strong Buy Rating and $4.75 PT on Oculus Innovative Sciences - Benzinga 11.09.11 | 09:11 am
- A Look at 5 Stocks in the Green Wednesday - Seeking Alpha 07.28.11 | 09:07 am
- UPDATE 1-Oculus skin and wound gel gets FDA approval - Reuters 03.10.10 | 08:03 am
